Latest Breaking News On - Development paths for oncology - Page 1 : comparemela.com

PharmaDrug Inc : PharmaDrug Advances Programs in Oncology with Filing of PCT Application Detailing the Use of PD-001 for Treatment of Prostate Cancer

Toronto, Ontario (Newsfile Corp. - January 31, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development

United statesWangy cepharanthineDaniel cohenBaillyc cepharanthineNewsfile corpDevelopment paths for oncologyPharmadrug incDrug administrationPatent cooperation treatySet forthCentered around demonstrated benefitPre clinical prostate cancerProvisional patentValidated studies support potentialDevelopment pathsInfectious disease create

PharmaDrug Advances Programs in Oncology and Infectious Disease through Completion of cGMP Drug Substance Manufacturing

Toronto - PharmaDrug Inc. , a specialty pharmaceutical company focused on the research, development and commercialization of psychedelics and other naturally-derived approved drugs, is pleased to. | October 5, 2022

United statesDaniel cohenDevelopment paths for oncologyPharmadrug incDrug administrationGenvion corporationDevelopment pathsInfectious disease createEnteric coated oral cepharanthineValidated studies reveal potentialEnabling prostate cancerProvisional patentSairiyo therapeuticsSuper smartNews publishingPharmadrug inc stock exchange

PharmaDrug Advances Programs in Oncology and Infectious Disease Through Completion of cGMP Drug Substance Manufacturing

PharmaDrug Advances Programs in Oncology and Infectious Disease Through Completion of cGMP Drug Substance Manufacturing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth africaJapan generalSouth africanWangy cepharanthineDaniel cohenBaillyc cepharanthineNewsfile corpDevelopment paths for oncologyPharmadrug incDrug administrationGenvion corporationDevelopment pathsInfectious disease createEnteric coated oral cepharanthineValidated studies reveal potential

PharmaDrug Inc : PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Disease

Completes qualification of all necessary analytical methodologies to support production of Cepharanthine-2HCL drug substanceClinical trial-scale production of cGMP Cepharanthine-2HCL drug substance scheduled

United statesSouth africaJapan generalSouth africanWangy cepharanthineDaniel cohenBaillyc cepharanthineNewsfile corpDevelopment paths for oncologyPharmadrug incDrug administrationGenvion corporationDevelopment pathsInfectious disease createEnteric coated oral cepharanthineValidated studies reveal potential

PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Diseas

PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Diseas
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.